// App-Quantinova.ai

e14040 : The safety of four cycles of CAPEOX combined with radiotherapy vs. capecitabine combine with radiotherapy for locally advanced rectal cancer: Mid-term analysis of NCT02031939.

Researchers

Presenter

  • Rong-xin Zhang

Principal Investigators

  • Zhen-hai LU

  • Fu-long WANG

  • Desen Wan

  • Yuan-Hong Gao

  • Zhi-Fan Zeng

  • Pei-Rong Ding

  • Xiao Jun Wu

  • Li-ren LI

  • Jun-Zhong Lin

Medical Centers

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

  • Department of Breast Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China

  • State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Sun Yat-Sen University Cancer Center, Guangdzhou, Guangdong, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Capecitabine

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • NCT02031939

Sponsors

  • N/A

Result

  • Final